Stephen J.LurieMD, PhD, Senior EditorIndividualAuthor
To the Editor: While I strongly support Dr Kassirer's1 view that it is wrong to accept perks from the pharmaceutical industry, should prestigious journals, such as the one that Dr Kassirer edited, act as well-paid conduits for drug advertisements? Readers have been told that their subscription fee pays for the journal,2 so the advertising money turns into a pure perk, bonus, or cold cash for someone. Maybe medical journals should no longer accept any advertisements for drugs and let pure science speak for itself: if drugs are well studied and the results appropriately published, they will be properly used, even without expensive and glitzy ads.
Pierach CA. Free Meals From the Pharmaceutical Industry. JAMA. 2001;285(2):164–166. doi:10.1001/jama.285.2.163
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: